Beyond skin diseases, DGAT2 is also implicated in systemic inflammatory diseases, like metabolic dysfunction–associated steatohepatitis (MASH) (43), diabetes (44), and atherosclerosis (45). Here, DGAT2 is linked to metabolic dysfunction-associated steatohepatitis.